Research and experimental development on natural sciences and engineering
ZELLUNA IMMUNOTHERAPY AS
Revenue 2024
NOK 53,000
Operating profit
NOK −109.6m
Equity
NOK 36.0m
Incorporated
2016
Employees
9
Share capital
NOK 2.0m
Register information
- Legal form
- Limited company (AS)
- Industry
- Research and experimental development on natural sciences and engineering (72.100)
- Sector
- Private non-financial incorporated enterprises
- Incorporated
- 25 Jan 2016
- Registered
- 1 Mar 2016
- Employees
- 9
- Municipality
- OSLO
- County
- Oslo
- Latest accounts
- 2024
Contact
- Address
- Ullernchausséen 64, 0379 OSLO
Registers
MVA-registretJa
ForetaksregisteretJa
StiftelsesregisteretNei
FrivillighetsregisteretNei
Share capital
- Type
- Aksjekapital
- Amount
- NOK 2.0m NOK
- Number of shares
- 13524826
- Registered
- 26 May 2026
Purpose and activity
- Articles of association
- 2026-05-20
- Purpose
- Utvikle, markedsføre og selge medisinske produkter og utstyr samt det som står i forbindelse med dette.
- Activity
- Utvikle legemidler mot kreft.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.